160 related articles for article (PubMed ID: 30487673)
1. Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention for coronary stenosis: a multicenter cross-sectional study.
Hara A; Ota K; Takeuchi T; Kojima Y; Hirata Y; Ozaki H; Kawaguchi S; Takahashi Y; Harada S; Sakanaka T; Ogura T; Nouda S; Kakimoto K; Kawakami K; Asai A; Fukunishi S; Sanomura M; Tominaga K; Higuchi K
J Clin Biochem Nutr; 2018 Nov; 63(3):224-229. PubMed ID: 30487673
[TBL] [Abstract][Full Text] [Related]
2. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R
Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638
[TBL] [Abstract][Full Text] [Related]
3. Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury.
Han Y; Liao Z; Li Y; Zhao X; Ma S; Bao D; Qiu M; Deng J; Wang J; Qu P; Jiang C; Jia S; Yang S; Ru L; Feng J; Gao W; Huang Y; Tao L; Han Y; Yang K; Wang X; Zhang W; Wang B; Li Y; Yang Y; Li J; Sheng J; Ma Y; Cui M; Ma S; Wang X; Li Z; Stone GW
J Am Coll Cardiol; 2022 Jan; 79(2):116-128. PubMed ID: 34752902
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy.
Harada H; Suehiro S; Murakami D; Nakahara R; Nagasaka T; Ujihara T; Sagami R; Katsuyama Y; Hayasaka K; Amano Y
World J Gastroenterol; 2019 Jan; 25(4):457-468. PubMed ID: 30700942
[TBL] [Abstract][Full Text] [Related]
5. Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin.
Tsujimoto H; Hirata Y; Ueda Y; Kinoshita N; Tawa H; Tanaka Y; Koshiba R; Ota K; Kojima Y; Kakimoto K; Takeuchi T; Miyazaki T; Nakamura S; Higuchi K
Eur J Clin Pharmacol; 2021 Nov; 77(11):1639-1648. PubMed ID: 34085115
[TBL] [Abstract][Full Text] [Related]
6. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
[No Abstract] [Full Text] [Related]
7. P2Y12 Inhibitors Exacerbate Low-dose Aspirin-induced Small Bowel Injury in Dual Antiplatelet Therapy.
Handa Y; Fukushima S; Osawa M; Murao T; Handa O; Matsumoto H; Umegaki E; Shiotani A
Intern Med; 2021; 60(22):3517-3523. PubMed ID: 34776464
[TBL] [Abstract][Full Text] [Related]
8. Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury.
Ito Y; Sasaki M; Noguchi S; Yamaguchi S; Okaniwa N; Tanabe A; Noda H; Yanamoto K; Tamura Y; Kondo Y; Masui R; Izawa S; Iida A; Mizuno M; Ogasawara N; Funaki Y; Kasugai K
United European Gastroenterol J; 2013 Aug; 1(4):259-64. PubMed ID: 24917970
[TBL] [Abstract][Full Text] [Related]
9. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Vaduganathan M; Bhatt DL; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Cannon CP;
J Am Coll Cardiol; 2016 Apr; 67(14):1661-71. PubMed ID: 27012778
[TBL] [Abstract][Full Text] [Related]
10. Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry.
Moalem K; Baber U; Chandrasekhar J; Claessen BE; Sartori S; Aquino M; Dangas G; Iakovou I; Colombo A; Kini A; Gibson M; Krucoff M; Chieffo A; Moliterno D; Witzenbichler B; Pocock S; Mehran R
Clin Res Cardiol; 2019 Jun; 108(6):643-650. PubMed ID: 30607496
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy.
Shimada Y; Hojo M; Kita Y; Ikeda Y; Sato S; Murata A; Sato S; Matsumoto K; Akazawa Y; Takeda T; Ueda K; Ueyama H; Shibuya T; Genda T; Nagahara A
Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292053
[TBL] [Abstract][Full Text] [Related]
12. Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.
Manchuelle A; Delhaye C; Schurtz G; Sudre A; Hurt C; Bonello L; Puymirat E; Bauters C; Lemesle G
Arch Cardiovasc Dis; 2015 Apr; 108(4):235-43. PubMed ID: 25682548
[TBL] [Abstract][Full Text] [Related]
13. Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial.
Gargiulo G; Costa F; Ariotti S; Biscaglia S; Campo G; Esposito G; Leonardi S; Vranckx P; Windecker S; Valgimigli M
Am Heart J; 2016 Apr; 174():95-102. PubMed ID: 26995375
[TBL] [Abstract][Full Text] [Related]
14. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
JAMA; 2019 Jun; 321(24):2414-2427. PubMed ID: 31237644
[TBL] [Abstract][Full Text] [Related]
15. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M
JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention.
Mauri L; Kirtane AJ; Windecker S; Yeh RW; Dauerman HL; Price MJ; Christen T; Allocco DJ; Meredith IT; Kereiakes DJ
Am Heart J; 2018 Nov; 205():110-117. PubMed ID: 30218844
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
Awaisu A; Hamou F; Mekideche L; El Muabby N; Mahfouz A; Mohammed S; Saad A
Int J Clin Pharm; 2016 Apr; 38(2):353-61. PubMed ID: 26749343
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.
Lee H; Koo BK; Park KW; Shin ES; Lim SW; Rha SW; Bae JW; Jeon DW; Oh SK; Hur SH; Kim BS; Lee JH; Park TH; Lee NH; Kim HS;
Am Heart J; 2017 Mar; 185():17-25. PubMed ID: 28267471
[TBL] [Abstract][Full Text] [Related]
19. Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).
Campo G; Tebaldi M; Vranckx P; Biscaglia S; Tumscitz C; Ferrari R; Valgimigli M
J Am Coll Cardiol; 2014 Feb; 63(6):506-12. PubMed ID: 24161321
[TBL] [Abstract][Full Text] [Related]
20. Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
Hahn JY; Song YB; Oh JH; Chun WJ; Park YH; Jang WJ; Im ES; Jeong JO; Cho BR; Oh SK; Yun KH; Cho DK; Lee JY; Koh YY; Bae JW; Choi JW; Lee WS; Yoon HJ; Lee SU; Cho JH; Choi WG; Rha SW; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC;
JAMA; 2019 Jun; 321(24):2428-2437. PubMed ID: 31237645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
